Written by Ernesto Londoño, Manuela Andreoni and Letícia Casado (Ernesto Londoño and Manuela Andreoni reported from Rio de Janeiro, and Letícia Casado from Brasília.)
As countries rushed their preparations to inoculate citizens against the coronavirus, Brazil, with its world-renowned immunization program and a robust pharmaceutical manufacturing capacity, should have been at a significant advantage.
But political infighting, haphazard planning and a nascent anti-vaccine movement have left the nation, which has suffered the pandemic’s second-largest death toll, without a clear vaccination program. Its citizens now have no sense of when they may get relief from a virus that has brought the public health system to its knees and crushed the economy.
“They’re playing with lives,” said Denise Garrett, a Brazilian American public health researcher at the Sabin Vaccine Institute, which works to expand access to vaccines. “It’s borderline criminal.”
Experts had held out hope that Brazil’s immunization prowess might allow it to handle the end of the pandemic better than it handled the beginning.
Soon after COVID-19 was first identified in the country in February, Brazil became an epicenter of the global health crisis. President Jair Bolsonaro dismissed scientific evidence, called the virus a “measly” cold that did not warrant shutting down the region’s largest economy, and berated governors who imposed quarantine measures and business closures.
As vaccination efforts get underway in Britain and the United States, giving their populations a chance to begin to imagine a post-pandemic life, the moment found Brazilian officials once again unprepared and mired in loud disputes over vaccine politics.
The health ministry last week presented a vaccination plan in response to an order from the Supreme Court. The plan established the order in which vulnerable groups would be vaccinated, but it lacked a detailed timeline and a clear estimate of how many doses will be available. The ministry had previously said it intended to start the vaccination campaign in March.
Days after the announcement, the health ministry was still scrambling to place orders with overextended vaccine suppliers. Officials at the ministry also faced questions over why the country did not have enough syringes and vials on hand to embark on the ambitious vaccination campaign, necessary to cover a country with 210 million residents, where more than 180,000 have succumbed to the virus.
On top of that, Anvisa, Brazil’s health regulatory agency, has yet to approve any coronavirus vaccine for general use.
“People are going to start to panic if Brazil continues to lag behind in having a plan, a clear and objective strategy,” Rodrigo Maia, the speaker of the House, said on Dec. 7, warning that Congress would take the reins of the process if the executive branch continued to fumble.
The discussion of vaccine access and safety has also become mired in a partisan dispute.
Bolsonaro has repeatedly maligned the CoronaVac vaccine, which is being developed by the Chinese firm Sinovac Biotech, and nixed his health ministry’s plan to purchase 46 million doses.
Instead, the government placed its faith in the vaccine developed by AstraZeneca and Oxford University, which is lagging in the race to receive approval from health regulators.
The president’s crusade against the Chinese vaccine created a golden political opportunity for one of his chief political rivals, João Doria, the governor of São Paulo state. Doria negotiated directly with the Chinese for doses of the vaccine, which is being developed in partnership with the São Paulo-based Butantan research center.
Doria said state officials could not wait for the federal government, which has cycled through three health ministers over the course of the pandemic, to get its act together.
“We can’t wait until March to start using a vaccine that can be used in January,” he said in an interview. “There’s a consensus in the state of São Paulo and other states that waiting poses a big risk for the population, affecting mortality rates and the public health care system.”
Doria promised his constituents last week that São Paulo intended to start vaccinating people in late January — a pledge contingent on obtaining approval from federal regulators, who have yet to receive the final results of studies of the vaccine’s efficacy and safety.
The president’s office condemned Doria’s plan to start vaccinating people in January, calling it “cheap and irresponsible populism.”
The increasingly bitter spat between Doria, who is widely expected to run for president in 2022, and the federal government has dangerously politicized vaccination plans in Brazil.
Carla Domingues, a public health researcher who ran Brazil’s immunization program until last year, lamented that the coronavirus vaccine had become a partisan issue.
“That has never happened in immunization efforts,” she said. “This is going to leave people confused. It’s surreal.”
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines